[{"bbox": [91, 98, 368, 131], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [89, 164, 1558, 2113], "category": "Table", "text": "<table><tr><td></td><td>in public offers using UPI Mechanism is provided as Annexure 'A' to the SEBI circular no. SEBI/HO/CFD/DIL2/CIR/P/2019/85 dated July 26, 2019. The said list shall be updated on SEBI website.</td></tr><tr><td>Specified Locations</td><td>Collection centres where the SCSBs shall accept application form, a list of which is available on the website of SEBI (https://www.sebi.gov.in/) and updated from time to time</td></tr><tr><td>Specified Securities</td><td>Equity shares issued through this Draft Red Herring Prospectus.</td></tr><tr><td>Sponsor Bank</td><td>A Banker to the Issue which is registered with SEBI and is eligible to act as a Sponsor Bank in a public Issue in terms of applicable SEBI requirements and has been appointed by the Company, in consultation with the BRLMs to act as a conduit between the Stock Exchanges and NPCI to push the UPI Mandate Request in respect of UPI Bidders as per the UPI Mechanism and carry out other responsibilities in terms of the UPI Circulars, in this case being [•].</td></tr><tr><td>Sub Syndicate Member</td><td>A SEBI Registered member of NSE appointed by the BRLMs and / or syndicate member to act as a Sub Syndicate Member in the Issue.</td></tr><tr><td>Syndicate</td><td>Includes the BRLMs, Syndicate Members and Sub Syndicate Members.</td></tr><tr><td>Syndicate Agreement</td><td>Agreement to be entered into amongst our Company, the BRLMs and the Syndicate Members, in relation to the collection of Bid cum Application Forms by the Syndicate Members.</td></tr><tr><td>Syndicate ASBA Bidding Locations</td><td>Bidding Centres where an ASBA Bidder can submit their Bid in terms of SEBI Circular no. CIR/CFD/DIL/1/2011 dated April 29, 2011.</td></tr><tr><td>Syndicate Members / Members of the Syndicate</td><td>Intermediaries registered with SEBI eligible to act as a syndicate member and who is permitted to carry on the activity as an underwriter, in this case being [•].</td></tr><tr><td>Syndicate or members of the Syndicate</td><td>Collectively, the BRLMs and the Syndicate Members.</td></tr><tr><td>Systemically Important Non - Banking Financial Company</td><td>Systemically important non-banking financial company as defined under Regulation 2(1) (iii) of the SEBI ICDR Regulations.</td></tr><tr><td>Transaction Registration Slip/ TRS</td><td>The slip or document issued by the member of the Syndicate or SCSB (only on demand) as the case may be, to the Bidder as proof of registration of the Application.</td></tr><tr><td>U.S. Securities Act</td><td>U.S. Securities Act of 1933, as amended</td></tr><tr><td>Underwriter</td><td>The BRLMs and the Underwriter, who have underwritten this Issue pursuant to the provisions of the SEBI (ICDR) Regulations, 2018 and the Securities and Exchange Board of India (Underwriters) Regulations, 1993, as amended from time to time.</td></tr><tr><td>Underwriting Agreement</td><td>The Agreement dated [•] entered between the Underwriter(s) and our Company.</td></tr><tr><td>UPI</td><td>Unified payments interface which is an instant payment mechanism, developed by the National Payment Corporation of India.</td></tr><tr><td>UPI Bidders</td><td>Collectively, individual investors applying as (i) Individual Investors (ii) Non-Institutional Bidders with an application size of up to Rs. 500,000 in the non-institutional Portion, and Bidding under the UPI Mechanism through ASBA Form(s) submitted with Syndicate Members, Registered Brokers, Collecting Depository Participants and Registrar and Share Transfer Agent. Pursuant to Circular no. SEBI/HO/CFD/DIL2/P/CIR/P/2022/45 dated April 5, 2022 issued by SEBI, all individual investors applying in public offers where the application amount is up to Rs. 500,000 shall use UPI and shall provide their UPI ID in the Application Form submitted with: (i) a syndicate member, (ii) a stock broker registered with a recognized stock exchange (whose name is mentioned on the website of the stock exchange as eligible for such activity), (iii) a depository participant (whose name is mentioned on the website of the stock exchange as eligible for such activity), and (iv) a registrar to an Issue and share transfer agent (whose name is mentioned on the website of the stock exchange as eligible for such activity)</td></tr><tr><td>UPI Circulars</td><td>Circular number CIR/CFD/POLICYCELL/11/2015 dated November 10, 2015 issued by SEBI, as amended by its Circular number SEBI/HO/CED/DIL/CIR/2016/26 dated January 21, 2016 and Circular number SEBI/HO/CFD/DIL2/CIR/P/2018/138 dated November 1, 2018 issued by SEBI as amended or modified by SEBI from time to time, including Circular number SEBI/HO/CFD/DIL2/CIR/P/2019/50 dated April 3, 2019, Circular number SEBI/HO/CFD/DIL2/CIR/P/2019/76 dated June 28, 2019, Circular number SEBI/HO/CFD/DIL2/CIR/P/2019/85 dated July 26, 2019, Circular number SEBI/HO/CFD/DCR2/CIR/P/2019/133 dated November 8, 2019, Circular number SEBI/HO/CFD/DIL2/CIR/P/2020/50 dated March 30, 2020, SEBI circular no. SEBI/HO/CFD/DIL2/CIR/P/2021/2480/1/M dated March 16, 2021, SEBI circular no. SEBI/HO/CFD/DIL2/P/CIR/2021/570 dated June 2, 2021, SEBI circular no. SEBI/HO/CFD/DIL2/P/CIR/P/2022/45 dated April 5, 2022 as amended pursuant to SEBI circular no.</td></tr></table>"}, {"bbox": [815, 2171, 833, 2198], "category": "Page-footer", "text": "9"}]